CWM
DMAC icon

Cornerstone Wealth Management’s DiaMedica Therapeutics DMAC Stock Holding History

Cornerstone Wealth Management’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$110K Hold
16,250
– – 0.01% 694
2025
Q4 		$129K Hold
16,250
– – 0.01% 674
2025
Q3 		$112K Hold
16,250
– – 0.01% 667
2025
Q2 		$63.4K Hold
16,250
– – ﹤0.01% 641
2025
Q1 		$61.6K Buy
+16,250
New +$92.9K ﹤0.01% 597

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cornerstone Wealth Management's DMAC Position: Q1 2026 in Review

Cornerstone Wealth Management held its DiaMedica Therapeutics (DMAC) position steady in Q1 2026 at 16,250 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #694.

Cornerstone Wealth Management first reported a position in DMAC in Q1 2025 and has held it in 5 quarters since. The position peaked at $129K in Q4 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • Cornerstone Wealth Management held 16,250 shares of DiaMedica Therapeutics worth $110K as of Q1 2026.
  • Cornerstone Wealth Management left its DiaMedica Therapeutics share count unchanged in Q1 2026.
  • DiaMedica Therapeutics made up 0.01% of Cornerstone Wealth Management's portfolio in Q1 2026, its #694 holding.
  • Cornerstone Wealth Management first reported a position in DiaMedica Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Cornerstone Wealth Management's DiaMedica Therapeutics position peaked at $129K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Cornerstone Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.